In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series D leads to $15mm for Barrx Medical

Executive Summary

Barrx Medical Inc. (endoscopic treatments for gastrointestinal diseases) completed a $15mm Series D financing round led by first-time investors Highland Capital Partners, which adds a board member and was joined by returning shareholders Delphi Ventures, Alloy Ventures, Frazier Healthcare Ventures, Sutter Hill Ventures, and Greenspring Associates. The company will utilize the funds to identify new applications for its HALO bipolar radiofrequency technology and expand its use into new markets around the world.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Radiofrequency Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies